Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Primary brain tumours in adults
10.1016/s0140-6736(18)30990-5 · 2018 · External reference
Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System
2021 · External reference
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
10.1056/nejmoa1402121 · 2015 · External reference
Survival and low-grade glioma: the emergence of genetic information
10.3171/2014.10.focus12367 · 2015 · External reference
10.1634/theoncologist.2013-0345
10.1634/theoncologist.2013-0345 · External reference
Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification
10.1038/s41598-017-19014-1 · 2018 · External reference
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
2016 · External reference
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033–26033): a randomised, open-label, phase 3 intergroup study
2016 · External reference
10.1200/jco.2010.33.2312
10.1200/jco.2010.33.2312 · External reference
10.1038/nrc2714
10.1038/nrc2714 · External reference
10.1038/nature12626
10.1038/nature12626 · External reference
10.1038/s41598-017-14364-2
10.1038/s41598-017-14364-2 · External reference
Cell Reversal From a Differentiated to a Stem-Like State at Cancer Initiation
10.3389/fonc.2020.00541 · 2020 · External reference
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting
10.3390/ijms21155278 · 2020 · External reference
10.1016/j.canlet.2014.12.028
10.1016/j.canlet.2014.12.028 · External reference
10.1007/s11060-017-2379-y
10.1007/s11060-017-2379-y · External reference
Conventional Treatment of Glioblastoma Reveals Persistent CD44 Subpopulations
10.1007/s12035-020-02004-2 · 2020 · External reference
10.1016/j.stem.2014.01.005
10.1016/j.stem.2014.01.005 · External reference
Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment
10.1371/journal.pone.0032453 · 2012 · External reference
10.1038/nature21029
10.1038/nature21029 · External reference
Unresolved reference
2022 · External reference
Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression
10.1038/onc.2016.55 · 2016 · External reference
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
10.1172/jci121266 · 2019 · External reference
Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme
10.3389/fgene.2021.633812 · 2021 · External reference
10.1371/journal.pone.0116644
10.1371/journal.pone.0116644 · External reference
10.1158/0008-5472.can-16-2310
10.1158/0008-5472.can-16-2310 · External reference
Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma
10.1016/j.ccell.2019.05.003 · 2019 · External reference
10.1016/j.it.2004.09.015
10.1016/j.it.2004.09.015 · External reference
Crosstalk Between Tumor-Associated Microglia/Macrophages and CD8-Positive T Cells Plays a Key Role in Glioblastoma
10.3389/fimmu.2021.650105 · 2021 · External reference
10.1038/ncomms3612
10.1038/ncomms3612 · External reference
10.1038/nmeth.3337
10.1038/nmeth.3337 · External reference
10.1093/nar/gkaa1074
10.1093/nar/gkaa1074 · External reference
10.1038/s41587-020-0546-8
10.1038/s41587-020-0546-8 · External reference
pROC: an open-source package for R and S+ to analyze and compare ROC curves
10.1186/1471-2105-12-77 · 2011 · External reference
10.1093/bioinformatics/btp692
10.1093/bioinformatics/btp692 · External reference
10.1371/journal.pone.0017238
10.1371/journal.pone.0017238 · External reference
10.1089/omi.2011.0118
10.1089/omi.2011.0118 · External reference
The Molecular Signatures Database (MSigDB) hallmark gene set collection
10.1016/j.cels.2015.12.004 · 2015 · External reference
10.1101/gr.1239303
10.1101/gr.1239303 · External reference
10.1186/1752-0509-8-s4-s11
10.1186/1752-0509-8-s4-s11 · External reference
10.1016/j.neuron.2011.07.022
10.1016/j.neuron.2011.07.022 · External reference
10.1083/jcb.85.3.890
10.1083/jcb.85.3.890 · External reference
Integrated analysis of multimodal single-cell data
2021 · External reference
10.1038/s41592-019-0619-0
10.1038/s41592-019-0619-0 · External reference
10.1038/s41587-020-00795-2
10.1038/s41587-020-00795-2 · External reference
10.1038/s41596-020-0292-x
10.1038/s41596-020-0292-x · External reference
Unresolved reference
External reference
Old Stars and New Players in the Brain Tumor Microenvironment
10.3389/fncel.2021.709917 · 2021 · External reference
10.1002/glia.23718
10.1002/glia.23718 · External reference
10.1158/2159-8290.cd-19-0329
10.1158/2159-8290.cd-19-0329 · External reference
10.1126/science.aai8478
10.1126/science.aai8478 · External reference
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas
10.1111/bpa.12690 · 2019 · External reference
10.1038/s41593-020-00789-y
10.1038/s41593-020-00789-y · External reference
10.1016/j.ccr.2012.02.022
10.1016/j.ccr.2012.02.022 · External reference
10.1038/labinvest.2017.19
10.1038/labinvest.2017.19 · External reference
Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth
2020 · External reference
Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review
10.2147/ijn.s243223 · 2020 · External reference
Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
2019 · External reference
Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
10.3389/fcell.2021.706286 · 2021 · External reference
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment
10.18632/aging.101415 · 2018 · External reference
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
10.3389/fimmu.2020.603341 · 2020 · External reference
10.1016/j.canlet.2016.01.024
10.1016/j.canlet.2016.01.024 · External reference
Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis
10.7314/apjcp.2014.15.16.6761 · 2014 · External reference
Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis
10.5301/jbm.5000224 · 2017 · External reference
The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
2017 · External reference
Expression of CD44 and the survival in glioma: a meta-analysis
2020 · External reference
Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
2020 · External reference
Prognostic value of stem cell markers in glioblastoma
10.1080/1354750x.2019.1652345 · 2019 · External reference
Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival
10.1155/2018/9628289 · 2018 · External reference
Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
2019 · External reference
Immunohistochemical expression of stem cell markers CD44 and nestin in glioblastomas: Evaluation of their prognostic significance
10.1016/j.prp.2016.07.002 · 2016 · External reference
Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas
10.1007/s11060-019-03288-8 · 2019 · External reference
Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
10.1155/2018/5387041 · 2018 · External reference
Mesenchymal subtype of glioblastomas with high DNA-PKcs expression is associated with better response to radiotherapy and temozolomide
10.1007/s11060-016-2367-7 · 2017 · External reference
CD44 expression in human gliomas
10.1002/jso.10045 · 2002 · External reference
10.3109/0284186x.2014.951492
10.3109/0284186x.2014.951492 · External reference
Evaluation of the prognostic value of CD44 in glioblastoma multiforme
2010 · External reference
A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
10.3389/fonc.2020.605737 · 2020 · External reference
Suppression of CD44 expression decreases migration and invasion of human glioma cells
10.1002/(sici)1097-0215(19960410)66:2<255::aid-ijc20>3.0.co;2-a · 1996 · External reference
10.1523/jneurosci.6221-11.2012
10.1523/jneurosci.6221-11.2012 · External reference
Glioblastoma cell line-derived spheres in serum-containing medium versus serum-free medium: a comparison of cancer stem cell properties
10.3892/ijo.2012.1592 · 2012 · External reference
10.1097/01.jnen.0000178445.33972.a9
10.1097/01.jnen.0000178445.33972.a9 · External reference
Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade
10.1523/jneurosci.23-10-04034.2003 · 2003 · External reference
10.1016/j.ccr.2005.10.012
10.1016/j.ccr.2005.10.012 · External reference
Midkine activation of CD8 T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth
10.1038/s41467-020-15770-3 · 2020 · External reference
10.1016/j.ccell.2017.07.006
10.1016/j.ccell.2017.07.006 · External reference
10.1093/neuonc/noy082
10.1093/neuonc/noy082 · External reference
10.18632/oncotarget.8064
10.18632/oncotarget.8064 · External reference
10.1016/j.canlet.2019.03.032
10.1016/j.canlet.2019.03.032 · External reference
Crosstalk between M2 macrophages and glioma stem cells
2017 · External reference
Glioma stem cell (GSC)-derived autoschizis-like products confer GSC niche properties involving M1-like tumor-associated macrophages
10.1002/stem.3193 · 2020 · External reference
10.1016/j.celrep.2021.109718
10.1016/j.celrep.2021.109718 · External reference
Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo
10.1002/ijc.29454 · 2015 · External reference
Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
10.1186/s12935-022-02510-4 · 2022 · External reference
Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin
2002 · External reference
High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
10.2147/cmar.s233423 · 2020 · External reference
